These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 3016522)

  • 1. Differential transformation of C3H10T1/2 cells by v-mos: sequential expression of transformation parameters.
    van der Hoorn FA; Müller V
    Mol Cell Biol; 1985 Sep; 5(9):2204-11. PubMed ID: 3016522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of the mouse mammary tumor virus long terminal repeat to promote steroid-inducible expression of v-mos.
    Papkoff J; Ringold GM
    J Virol; 1984 Nov; 52(2):420-30. PubMed ID: 6092668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A common cellular pathway for v-mos and v-Ki-ras is not required for v-Ki-ras-induced tumorigenicity in a nonmalignant, v-mos-expressing revertant cell.
    Gerfaux J; Sergiescu D; Hamelin R; Joret AM; Lallemand C
    Mol Carcinog; 1990; 3(2):103-13. PubMed ID: 2161237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The v-mos and H-ras oncogene expression represses glucocorticoid hormone-dependent transcription from the mouse mammary tumor virus LTR.
    Jaggi R; Salmons B; Muellener D; Groner B
    EMBO J; 1986 Oct; 5(10):2609-16. PubMed ID: 3023051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functions of the mos oncogene family and associated gene products.
    Bold RJ; Hannink M; Donoghue DJ
    Cancer Surv; 1986; 5(2):243-55. PubMed ID: 2946405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibody detection of transformation associated protein (TAP) in ts110 Moloney murine sarcoma virus transformed 6M2 cells that are different from the mos gene product.
    Chan JC; Keck ME; Li W
    Biochem Biophys Res Commun; 1986 Feb; 134(3):1223-30. PubMed ID: 3004486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent expression of v-mos oncogene in transformed cells that revert to nonmalignancy after prolonged treatment with interferon.
    Sergiescu D; Gerfaux J; Joret AM; Chany C
    Proc Natl Acad Sci U S A; 1986 Aug; 83(16):5764-8. PubMed ID: 3016718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demonstration of biological activity and nucleotide sequence of an in vitro synthesized clone of the Moloney murine sarcoma virus mos gene.
    Donoghue DJ
    J Virol; 1982 May; 42(2):538-46. PubMed ID: 7045395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of activated and normal mouse Mos gene in murine 3T3 cells.
    Paules RS; Resnick J; Kasenally AB; Ernst MK; Donovan P; Vande Woude GF
    Oncogene; 1992 Dec; 7(12):2489-98. PubMed ID: 1461652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of the 78A1 isolate of Moloney murine sarcoma virus. I. Molecular cloning and characterization.
    Devaux J; Jouanneau J; Quibriac M; Longuet M; Le Bousse-Kerdiles MC; Auger-Buendia MA; Tavitian A
    J Gen Virol; 1985 Nov; 66 ( Pt 11)():2407-14. PubMed ID: 2997374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the v-mos gene alters a Mr 55,000 protein during acute infection by Moloney murine sarcoma virus.
    Singh B; Sparrow JT; Hedge AM; Arlinghaus RB
    Proc Natl Acad Sci U S A; 1986 Jun; 83(11):3629-33. PubMed ID: 3012522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long terminal repeat sequences impart hematopoietic transformation properties to the myeloproliferative sarcoma virus.
    Stocking C; Kollek R; Bergholz U; Ostertag W
    Proc Natl Acad Sci U S A; 1985 Sep; 82(17):5746-50. PubMed ID: 2994046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temperature-sensitive viral RNA expression in Moloney murine sarcoma virus ts110-infected cells.
    Hamelin R; Brizzard BL; Nash MA; Murphy EC; Arlinghaus RB
    J Virol; 1985 Feb; 53(2):616-23. PubMed ID: 2982039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of specific transformation-associated proteins (TAPs) in two rat cell lines is closely related to the expression of the v-mos gene product of Moloney murine sarcoma virus (Mo-MSV).
    Li W; Bowen JM; Chan JC
    Intervirology; 1987; 28(1):50-6. PubMed ID: 2828268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular basis underlying phenotypic revertants of Moloney murine sarcoma virus MuSVts110.
    Cizdziel PE; Nash MA; Blair DG; Murphy EC
    J Virol; 1986 Jan; 57(1):310-7. PubMed ID: 3001354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular factors binding to a novel cis-acting element mediate steroid hormone responsiveness of mouse mammary tumor virus promoter.
    Lee KI; Reddy EP; Reddy CD
    J Biol Chem; 1995 Oct; 270(41):24502-8. PubMed ID: 7592667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular Moloney murine sarcoma (c-mos) sequences are hypermethylated and transcriptionally silent in normal and transformed rodent cells.
    Gattoni S; Kirschmeier P; Weinstein IB; Escobedo J; Dina D
    Mol Cell Biol; 1982 Jan; 2(1):42-51. PubMed ID: 6287220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temperature-sensitive splicing defect of ts110 Moloney murine sarcoma virus is virus encoded.
    Hamelin R; Kabat K; Blair D; Arlinghaus RB
    J Virol; 1986 Jan; 57(1):301-9. PubMed ID: 3001353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. v-mos proteins encoded by myeloproliferative sarcoma virus and its ts159 mutant.
    Singh B; Stocking C; Walker R; Yang YD; Ostertag W; Arlinghaus RB
    J Virol; 1992 Feb; 66(2):1267-72. PubMed ID: 1309903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A threshold effect in the induction of tumorigenicity of an established human cell line by v-mos.
    O'Hara BM; Blair DG
    Oncogene; 1988 Sep; 3(3):295-9. PubMed ID: 2974527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.